Back to results
US 2026/0217860 A1Published application
Anti-egfr/muc1 antibodies and uses thereof
AssigneeBiocytogen Pharmaceuticals (Beijing) Co., Ltd.
InventorsYifu Zhang, Yanfei Han, Zhuolin Li, Chengzhang Shang, Yi Yang, Yuelei Shen
Life of this patent
Estimating the term…
Abstract
It relates to anti-EGFR/MUC1 antibodies, and antibody drug conjugates derived therefrom, and the use thereof.
Claims55
An anti-EGFR/MUC1 antibody or antigen-binding fragment thereof, comprising:
- a first antigen-binding domain that specifically binds to EGFR;
- and a second antigen-binding domain that specifically binds to MUC1.
Dependencies are inferred from the claim text.